Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Defects of mitochondrial RNA turnover lead to the accumulation of double-stranded RNA in vivo.

Pajak A, Laine I, Clemente P, El-Fissi N, Schober FA, Maffezzini C, Calvo-Garrido J, Wibom R, Filograna R, Dhir A, Wedell A, Freyer C, Wredenberg A.

PLoS Genet. 2019 Jul 31;15(7):e1008240. doi: 10.1371/journal.pgen.1008240. eCollection 2019 Jul.

2.

Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells.

Biosa A, De Lazzari F, Masato A, Filograna R, Plotegher N, Beltramini M, Bubacco L, Bisaglia M.

Neurotox Res. 2019 Nov;36(4):746-755. doi: 10.1007/s12640-019-00078-y. Epub 2019 Jun 21.

PMID:
31228093
3.

Modulation of mtDNA copy number ameliorates the pathological consequences of a heteroplasmic mtDNA mutation in the mouse.

Filograna R, Koolmeister C, Upadhyay M, Pajak A, Clemente P, Wibom R, Simard ML, Wredenberg A, Freyer C, Stewart JB, Larsson NG.

Sci Adv. 2019 Apr 3;5(4):eaav9824. doi: 10.1126/sciadv.aav9824. eCollection 2019 Apr.

4.

Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss.

Biosa A, Sanchez-Martinez A, Filograna R, Terriente-Felix A, Alam SM, Beltramini M, Bubacco L, Bisaglia M, Whitworth AJ.

Hum Mol Genet. 2018 May 1;27(9):1618-1629. doi: 10.1093/hmg/ddy069.

5.

A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease.

Kauppila JHK, Baines HL, Bratic A, Simard ML, Freyer C, Mourier A, Stamp C, Filograna R, Larsson NG, Greaves LC, Stewart JB.

Cell Rep. 2016 Sep 13;16(11):2980-2990. doi: 10.1016/j.celrep.2016.08.037.

6.

The Clinical Use of the Neutrophil to Lymphocyte Ratio (NLR) in Urothelial Cancer: A Systematic Review.

Marchioni M, Primiceri G, Ingrosso M, Filograna R, Castellan P, De Francesco P, Schips L.

Clin Genitourin Cancer. 2016 Dec;14(6):473-484. doi: 10.1016/j.clgc.2016.04.008. Epub 2016 Apr 22. Review.

PMID:
27209348
7.

Erratum to: Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells.

Russo I, Berti G, Plotegher N, Bernardo G, Filograna R, Bubacco L, Greggio E.

J Neuroinflammation. 2016 Apr 1;13(1):70. doi: 10.1186/s12974-016-0535-5. No abstract available.

8.

Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE.

Filograna R, Godena VK, Sanchez-Martinez A, Ferrari E, Casella L, Beltramini M, Bubacco L, Whitworth AJ, Bisaglia M.

J Biol Chem. 2016 Apr 22;291(17):9257-67. doi: 10.1074/jbc.M115.708057. Epub 2016 Mar 7.

9.

Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells.

Russo I, Berti G, Plotegher N, Bernardo G, Filograna R, Bubacco L, Greggio E.

J Neuroinflammation. 2015 Dec 9;12:230. doi: 10.1186/s12974-015-0449-7. Erratum in: J Neuroinflammation. 2016;13(1):70.

10.

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Filograna R, Beltramini M, Bubacco L, Bisaglia M.

Curr Neuropharmacol. 2016;14(3):260-71. Review.

11.

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation.

Filograna R, Civiero L, Ferrari V, Codolo G, Greggio E, Bubacco L, Beltramini M, Bisaglia M.

PLoS One. 2015 Aug 28;10(8):e0136769. doi: 10.1371/journal.pone.0136769. eCollection 2015.

12.

Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?

Bisaglia M, Filograna R, Beltramini M, Bubacco L.

Ageing Res Rev. 2014 Jan;13:107-14. doi: 10.1016/j.arr.2013.12.009. Epub 2014 Jan 3. Review.

PMID:
24389159

Supplemental Content

Loading ...
Support Center